Process View
The network for 'negative regulation of g1 s transition of mitotic cell cycle' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
Any cell cycle regulatory process that prevents the commitment of a cell from G1 to S phase of the mitotic cell cycle.
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| RB1 | retinoblastoma 1 | 1.000 | |
| RBL2 | retinoblastoma-like 2 (p130) | 0.996 | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.993 | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.981 | |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.980 | |
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.948 | |
| CDK2 | cyclin-dependent kinase 2 | 0.935 | |
| RBL1 | retinoblastoma-like 1 (p107) | 0.896 | |
| CCND1 | cyclin D1 | 0.876 | |
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.868 | |
| XIAP | X-linked inhibitor of apoptosis | 0.769 | |
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.728 | |
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.705 | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.643 | |
| CDK6 | cyclin-dependent kinase 6 | 0.641 | |
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.637 | |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.565 | |
| E2F1 | E2F transcription factor 1 | 0.554 | |
| PAX3 | paired box 3 | 0.537 | |
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.452 | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.430 | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.403 | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.369 | |
| ARID1A | AT rich interactive domain 1A (SWI-like) | 0.337 | |
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.302 | |
| APAF1 | apoptotic peptidase activating factor 1 | 0.298 | |
| RBBP8 | retinoblastoma binding protein 8 | 0.287 | |
| EGFR | epidermal growth factor receptor | 0.283 | |
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.279 | |
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.268 | |
| WWOX | WW domain containing oxidoreductase | 0.259 | |
| BRCA1 | breast cancer 1, early onset | 0.243 | |
| LRDD | leucine-rich repeats and death domain containing | 0.242 | |
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.241 | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.240 | |
| BTRC | beta-transducin repeat containing | 0.236 | |
| E2F8 | E2F transcription factor 8 | 0.235 | |
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.221 | |
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.201 | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.174 | |
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.163 | |
| PCNA | proliferating cell nuclear antigen | 0.156 | |
| SMAD7 | SMAD family member 7 | 0.154 | |
| CCNE1 | cyclin E1 | 0.148 | |
| TP53 | tumor protein p53 | 0.146 | |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.146 | |
| RBBP4 | retinoblastoma binding protein 4 | 0.131 | |
| CCND3 | cyclin D3 | 0.127 | |
| HBP1 | HMG-box transcription factor 1 | 0.126 | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.124 | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.119 | |
| IER3 | immediate early response 3 | 0.111 | |
| NCOR1 | nuclear receptor corepressor 1 | 0.108 | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.103 | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.103 | |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.097 | |
| TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 0.094 | |
| UBE3A | ubiquitin protein ligase E3A | 0.094 | |
| YAP1 | Yes-associated protein 1 | 0.094 | |
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.093 | |
| NLRC4 | NLR family, CARD domain containing 4 | 0.092 | |
| RTF1 | Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.091 | |
| AR | androgen receptor | 0.091 | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.089 | |
| ARRB2 | arrestin, beta 2 | 0.085 | |
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.084 | |
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.082 | |
| POU5F1 | POU class 5 homeobox 1 | 0.080 | |
| E2F3 | E2F transcription factor 3 | 0.080 | |
| NCOA1 | nuclear receptor coactivator 1 | 0.079 | |
| ESR1 | estrogen receptor 1 | 0.073 | |
| TFDP1 | transcription factor Dp-1 | 0.070 | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.068 | |
| EP300 | E1A binding protein p300 | 0.068 | |
| FADD | Fas (TNFRSF6)-associated via death domain | 0.068 | |
| KRT5 | keratin 5 | 0.063 | |
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.062 | |
| MLLT1 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 | 0.061 | |
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.061 | |
| LIN9 | lin-9 homolog (C. elegans) | 0.061 | |
| UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.060 | |
| PURA | purine-rich element binding protein A | 0.060 | |
| E2F2 | E2F transcription factor 2 | 0.060 | |
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.058 | |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.058 | |
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.056 | |
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.055 | |
| POU3F2 | POU class 3 homeobox 2 | 0.053 | |
| PTCH1 | patched 1 | 0.051 | |
| RAD18 | RAD18 homolog (S. cerevisiae) | 0.050 | |
| STRN3 | striatin, calmodulin binding protein 3 | 0.049 | |
| TXNIP | thioredoxin interacting protein | 0.045 | |
| RPA1 | replication protein A1, 70kDa | 0.045 | |
| YY1 | YY1 transcription factor | 0.044 | |
| SMAD5 | SMAD family member 5 | 0.043 | |
| PINK1 | PTEN induced putative kinase 1 | 0.043 | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.043 | |
| IGF1R | insulin-like growth factor 1 receptor | 0.042 | |
| SATB2 | SATB homeobox 2 | 0.041 | |
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.041 |
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| Ras85D | Ras oncogene at 85D | 0.756 | |
| Dp | DP transcription factor | 0.589 | |
| Rbf | Retinoblastoma-family protein | 0.559 | |
| Akt1 | CG4006 gene product from transcript CG4006-RA | 0.513 | |
| yki | yorkie | 0.399 | |
| phl | pole hole | 0.347 | |
| smo | smoothened | 0.272 | |
| CycD | Cyclin D | 0.217 | |
| Mad | Mothers against dpp | 0.208 | |
| Rel | Relish | 0.170 | |
| brm | brahma | 0.168 | |
| D | Dichaete | 0.160 | |
| babo | baboon | 0.160 | |
| sd | scalloped | 0.152 | |
| e(y)3 | enhancer of yellow 3 | 0.137 | |
| imd | immune deficiency | 0.127 | |
| Cdk4 | Cyclin-dependent kinase 4 | 0.125 | |
| rl | rolled | 0.119 | |
| Su(H) | Suppressor of Hairless | 0.117 | |
| sax | saxophone | 0.117 | |
| Trf2 | TATA box binding protein-related factor 2 | 0.114 | |
| p53 | CG33336 gene product from transcript CG33336-RB | 0.081 | |
| Dcr-1 | Dicer-1 | 0.063 | |
| rap | retina aberrant in pattern | 0.062 | |
| Cbl | CG7037 gene product from transcript CG7037-RB | 0.058 | |
| wts | warts | 0.057 | |
| cdc2c | CG10498 gene product from transcript CG10498-RC | 0.057 | |
| Tsc1 | CG6147 gene product from transcript CG6147-RA | 0.054 | |
| CG9339 | CG9339 gene product from transcript CG9339-RG | 0.054 | |
| da | daughterless | 0.051 | |
| hep | hemipterous | 0.048 | |
| put | punt | 0.046 | |
| Su(z)12 | CG8013 gene product from transcript CG8013-RA | 0.046 | |
| Liprin-alpha | CG11199 gene product from transcript CG11199-RB | 0.045 | |
| nej | nejire | 0.044 | |
| eya | eyes absent | 0.038 | |
| Dap160 | Dynamin associated protein 160 | 0.037 | |
| tkv | thickveins | 0.035 | |
| CG5669 | CG5669 gene product from transcript CG5669-RA | 0.034 | |
| gbb | glass bottom boat | 0.034 | |
| RagA | CG11968 gene product from transcript CG11968-RA | 0.034 | |
| mus205 | mutagen-sensitive 205 | 0.033 | |
| CycA | Cyclin A | 0.030 | |
| lmg | lemming | 0.030 | |
| pygo | pygopus | 0.030 | |
| Myd88 | CG2078 gene product from transcript CG2078-RA | 0.029 | |
| Tis11 | Tis11 homolog | 0.029 | |
| EcR | Ecdysone receptor | 0.028 | |
| heph | hephaestus | 0.028 | |
| tld | tolloid | 0.027 | |
| MED26 | Mediator complex subunit 26 | 0.026 | |
| Nf-YA | Nuclear factor Y-box A | 0.024 | |
| Pc | Polycomb | 0.024 | |
| plu | plutonium | 0.024 | |
| Eps-15 | Epidermal growth factor receptor pathway substrate clone 15 | 0.023 | |
| kn | knot | 0.023 | |
| tefu | telomere fusion | 0.023 | |
| CG8455 | CG8455 gene product from transcript CG8455-RA | 0.023 | |
| jub | Ajuba LIM protein | 0.022 | |
| nct | nicastrin | 0.022 | |
| CycG | Cyclin G | 0.021 | |
| emc | extra macrochaetae | 0.020 | |
| simj | simjang | 0.020 | |
| JhI-1 | Juvenile hormone-inducible protein 1 | 0.020 | |
| MED17 | Mediator complex subunit 17 | 0.019 | |
| eff | effete | 0.019 | |
| swm | second mitotic wave missing | 0.018 | |
| Atg1 | Autophagy-specific gene 1 | 0.018 | |
| Imp | IGF-II mRNA-binding protein | 0.018 | |
| flower | CG6151 gene product from transcript CG6151-RA | 0.018 | |
| E2f | E2F transcription factor | 0.018 | |
| Set2 | CG1716 gene product from transcript CG1716-RA | 0.018 | |
| mip120 | Myb-interacting protein 120 | 0.017 | |
| mib1 | mind bomb 1 | 0.017 | |
| drosha | CG8730 gene product from transcript CG8730-RA | 0.017 | |
| GATAd | CG5034 gene product from transcript CG5034-RA | 0.017 | |
| ush | u-shaped | 0.016 | |
| DNApol-alpha50 | DNA polymerase alpha 50kD | 0.016 | |
| Brca2 | Breast cancer 2, early onset homolog | 0.016 | |
| Axn | Axin | 0.015 | |
| milt | milton | 0.015 | |
| E2f2 | E2F transcription factor 2 | 0.015 | |
| sav | salvador | 0.015 | |
| BG4 | CG12297 gene product from transcript CG12297-RA | 0.015 | |
| not | non-stop | 0.015 | |
| Rcd5 | Reduction in Cnn dots 5 | 0.015 | |
| Caf1-105 | CG12892 gene product from transcript CG12892-RA | 0.014 | |
| Nup160 | Nucleoporin 160 | 0.014 | |
| CycJ | Cyclin J | 0.014 | |
| ari-2 | ariadne 2 | 0.014 | |
| MED19 | Mediator complex subunit 19 | 0.014 | |
| FBX011 | FBX011 ortholog | 0.014 | |
| CG4973 | CG4973 gene product from transcript CG4973-RA | 0.014 | |
| mip130 | Myb-interacting protein 130 | 0.014 | |
| CG18754 | CG18754 gene product from transcript CG18754-RB | 0.013 | |
| CG7358 | CG7358 gene product from transcript CG7358-RA | 0.013 | |
| Kap-alpha3 | karyopherin alpha3 | 0.013 | |
| kek5 | kekkon5 | 0.013 | |
| nbs | CG6754 gene product from transcript CG6754-RC | 0.012 | |
| boca | CG30498 gene product from transcript CG30498-RA | 0.012 |
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| Trp53 | transformation related protein 53 | 0.999 | |
| Smarca4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.911 | |
| Rb1 | retinoblastoma 1 | 0.897 | |
| Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.645 | |
| Pten | phosphatase and tensin homolog | 0.613 | |
| Arid1b | AT rich interactive domain 1B (SWI-like) | 0.359 | |
| Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.301 | |
| Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.241 | |
| Apc | adenomatosis polyposis coli | 0.220 | |
| Nf1 | neurofibromatosis 1 | 0.200 | |
| Brca1 | breast cancer 1 | 0.200 | |
| Mdm4 | transformed mouse 3T3 cell double minute 4 | 0.184 | |
| Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.176 | |
| E2f1 | E2F transcription factor 1 | 0.159 | |
| Arid1a | AT rich interactive domain 1A (SWI-like) | 0.154 | |
| Smarcc1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.148 | |
| Cdkn2c | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.141 | |
| Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.133 | |
| Kit | kit oncogene | 0.107 | |
| Msh2 | mutS homolog 2 (E. coli) | 0.101 | |
| Smarca2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.090 | |
| Cd80 | CD80 antigen | 0.090 | |
| Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.076 | |
| Tgfb2 | transforming growth factor, beta 2 | 0.068 | |
| Ret | ret proto-oncogene | 0.062 | |
| Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.057 | |
| Aebp2 | AE binding protein 2 | 0.056 | |
| Cdk4 | cyclin-dependent kinase 4 | 0.056 | |
| Nbn | nibrin | 0.054 | |
| Ptch1 | patched homolog 1 | 0.052 | |
| Rbl2 | retinoblastoma-like 2 | 0.050 | |
| Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 0.044 | |
| Rbl1 | retinoblastoma-like 1 (p107) | 0.043 | |
| Ppp1cc | protein phosphatase 1, catalytic subunit, gamma isoform | 0.042 | |
| Stk11 | serine/threonine kinase 11 | 0.039 | |
| Smad4 | MAD homolog 4 (Drosophila) | 0.037 | |
| Atm | ataxia telangiectasia mutated homolog (human) | 0.036 | |
| Dicer1 | Dicer1, Dcr-1 homolog (Drosophila) | 0.033 | |
| Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.033 | |
| Braf | Braf transforming gene | 0.032 | |
| Foxo3 | forkhead box O3 | 0.032 | |
| Hif1a | hypoxia inducible factor 1, alpha subunit | 0.030 | |
| Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.029 | |
| Fgfr2 | fibroblast growth factor receptor 2 | 0.028 | |
| Bcl2 | B-cell leukemia/lymphoma 2 | 0.028 | |
| Cdkn2d | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 0.027 | |
| Bax | BCL2-associated X protein | 0.027 | |
| Erbb3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.025 | |
| Jarid2 | jumonji, AT rich interactive domain 2 | 0.025 | |
| Brca2 | breast cancer 2 | 0.024 | |
| Xpa | xeroderma pigmentosum, complementation group A | 0.022 | |
| Fgfr1 | fibroblast growth factor receptor 1 | 0.022 | |
| Isl1 | ISL1 transcription factor, LIM/homeodomain | 0.022 | |
| Bmpr1a | bone morphogenetic protein receptor, type 1A | 0.022 | |
| Ptpn13 | protein tyrosine phosphatase, non-receptor type 13 | 0.022 | |
| Shh | sonic hedgehog | 0.021 | |
| Meox2 | mesenchyme homeobox 2 | 0.020 | |
| Mdm2 | transformed mouse 3T3 cell double minute 2 | 0.020 | |
| Sin3a | transcriptional regulator, SIN3A (yeast) | 0.019 | |
| Tcf3 | transcription factor 3 | 0.019 | |
| Runx1 | runt related transcription factor 1 | 0.019 | |
| Nrg1 | neuregulin 1 | 0.018 | |
| Sirt1 | sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) | 0.018 | |
| Gfra1 | glial cell line derived neurotrophic factor family receptor alpha 1 | 0.017 | |
| Stk38 | serine/threonine kinase 38 | 0.017 | |
| Gja1 | gap junction protein, alpha 1 | 0.017 | |
| A930001N09Rik | RIKEN cDNA A930001N09 gene | 0.017 | |
| Zfp830 | zinc finger protein 830 | 0.016 | |
| Tfdp2 | transcription factor Dp 2 | 0.016 | |
| Lrrc58 | leucine rich repeat containing 58 | 0.016 | |
| Skil | SKI-like | 0.016 | |
| Tsc1 | tuberous sclerosis 1 | 0.015 | |
| Rara | retinoic acid receptor, alpha | 0.015 | |
| Pdcd1 | programmed cell death 1 | 0.015 | |
| Daxx | Fas death domain-associated protein | 0.015 | |
| Map3k7 | mitogen-activated protein kinase kinase kinase 7 | 0.015 | |
| Smarcb1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.015 | |
| Osbpl11 | oxysterol binding protein-like 11 | 0.015 | |
| Nfe2l2 | nuclear factor, erythroid derived 2, like 2 | 0.015 | |
| Hdac1 | histone deacetylase 1 | 0.014 | |
| Nf2 | neurofibromatosis 2 | 0.014 | |
| Cdk2 | cyclin-dependent kinase 2 | 0.014 | |
| Cdk6 | cyclin-dependent kinase 6 | 0.014 | |
| Numa1 | nuclear mitotic apparatus protein 1 | 0.014 | |
| Bak1 | BCL2-antagonist/killer 1 | 0.014 | |
| Rxra | retinoid X receptor alpha | 0.014 | |
| Cdkn2a | cyclin-dependent kinase inhibitor 2A | 0.013 | |
| Psen1 | presenilin 1 | 0.013 | |
| Kif16b | kinesin family member 16B | 0.012 | |
| Suz12 | suppressor of zeste 12 homolog (Drosophila) | 0.012 | |
| Cbl | Casitas B-lineage lymphoma | 0.012 | |
| Smarcd1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.012 | |
| Shc1 | src homology 2 domain-containing transforming protein C1 | 0.012 | |
| Ulk2 | Unc-51 like kinase 2 (C. elegans) | 0.012 | |
| Pik3ca | phosphatidylinositol 3-kinase, catalytic, alpha polypeptide | 0.012 | |
| Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.011 | |
| Ntf3 | neurotrophin 3 | 0.011 | |
| Hdac2 | histone deacetylase 2 | 0.011 | |
| Ccdc117 | coiled-coil domain containing 117 | 0.011 | |
| Pcna | proliferating cell nuclear antigen | 0.011 |